Voyager Therapeutics Inc. (VYGR) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Voyager Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$1.84
+6.36% today
Market cap
$107M
Overall quality
—
Kronos AI 30-day
+78.8%
8 of 8 simulated paths end higher
Voyager Therapeutics Inc. (VYGR) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $107M. It trades at $1.84, up 6.36% today. Kronos AI's 30-day forecast is +78.8% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
No analyst covers this listing yet.
Kronos AI 30-day forecast
| Expected close | $3.09 (+78.8%) |
| Likely range | +74.6% … +90.1% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.